Center-Authored Papers
Filters: Author is Le, Quynh-Thu X [Clear All Filters]
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009.
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract
.
2009. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)